Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Ciprofloxacin in Chronic Bacterial Prostatitis
NCT00236808Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of levofloxacin in chronic bacterial prostatitis (CBP), sponsored by Johnson & Johnson. Started May 2000; status: completed.
02
Drugs
levofloxacin
03
Conditions
chronic bacterial prostatitis (CBP)
Beyond the preview
Go deeper on NCT00236808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236808.